![Michael Gold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Gold
Hoofd Techniek/Wetenschap/O&O bij
COMPASS PATHWAYS PLC
Profiel
Michael Gold is currently the Chief Research & Development Officer at Compass Pathways Plc.
Previously, he worked as the Medical Director-Memory Disorder Clinic at the University of South Florida.
From 2017 to 2023, he served as the Vice President at AbbVie, Inc. In 2011 to 2013, he held the position of Chief Medical Officer at Allon Therapeutics, Inc. Additionally, from 2023 to 2024, he was the Chief Medical Officer at Neumora Therapeutics, Inc. Dr. Gold obtained his undergraduate, graduate, and doctorate degrees from the University of Miami.
Actieve functies van Michael Gold
| Bedrijven | Functie | Begin |
|---|---|---|
| COMPASS PATHWAYS PLC | Hoofd Techniek/Wetenschap/O&O | 01-05-2024 |
Eerdere bekende functies van Michael Gold
| Bedrijven | Functie | Einde |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 29-02-2024 |
| ABBVIE INC. | Corporate Officer/Principal | 01-01-2023 |
| ALLON THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | 01-01-2013 |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Opleiding van Michael Gold
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Allon Therapeutics, Inc.
 Allon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to protect against neurodegenerative conditions | Health Technology |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Compass Pathways Plc
 Compass Pathways Plc BiotechnologyHealth Technology Develops therapies and drugs for the treatment of mental health and neurocognitive conditions | Health Technology |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
